The White House has withdrawn the nomination of Heidi Overton to lead the Food and Drug Administration, according to a White House official who spoke with the Guardian.
President Donald Trump nominated Overton, a physician and prominent abortion opponent, in August. Overton has spent much of her professional career working directly for Trump or conservative groups aligned with his agenda. The August nomination was seen as an effort to bring a Trump loyalist into the agency after a turbulent year under Trump’s first FDA commissioner, Marty Makary.
Overton, however, faced bipartisan questions in the Senate about her willingness to break from Trump, particularly regarding his unsupported claims about the dangers of childhood vaccines.
Republican Senator Bill Cassidy of Louisiana, a physician who chairs the Senate health committee, said earlier Tuesday that he remained undecided about the nomination ahead of a scheduled vote by the Senate Health, Labor, Education, and Pensions Committee.
Cassidy had previously called Overton’s support for Trump’s plan to break up combination vaccines, including the measles, mumps and rubella shot, “almost disqualifying.” He also pressed her during the September hearing about her scientific independence and willingness to push back against Trump and Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic.
A prominent reproductive rights group celebrated the White House’s decision to withdraw Overton’s nomination.
Mini Timmaraju, president and CEO of Reproductive Freedom for All, formerly Naral Pro-Choice America, said: “Heidi Overton posed a serious threat to the future of medication abortion access. Voters rejected that anti-abortion agenda nationwide, and our members kept the pressure on to tank her confirmation. If Republicans try to rush through another nominee who threatens our healthcare, we’re ready to keep fighting.”
As head of the FDA, Overton would have overseen the agency that regulates medication abortions. In a 2023 policy brief for the conservative America First Policy Institute, Overton said Congress should strictly regulate the abortion pill mifeprestone “to protect women and children,” criticized federal policies that allow for the mailing of abortion pills, and wrote that abortion “is corrosive to children, women, and society broadly.”
To win confirmation, Overton would have needed the votes of all 12 Republicans on the Senate Health, Labor, Education, and Pensions Committee. Democrats hold 11 seats. Without support from the committee, Overton faced little chance of winning a full Senate vote on the chamber floor.
Republicans are racing to try to confirm all of Trump’s current nominees before they hand over power to Senate Democrats in January.
Also Read
- Trump’s APEC Agenda: Trade, Tech, and a Possible Trump-Xi-Putin Summit
- Pope Leo XIV Addresses Rosary Incident in Peru, Discloses Lung Cancer Surgery Details
- Pakistani National Sentenced to 27 Years in Prison for Iranian-Directed Plot to Assassinate Trump
- Board of Peace Warns Gaza Ceasefire Nears Collapse Amid Implementation Failures


